Mediterranean Diet in Familial Mediterranean Fever: Is Fatty Liver Affected by Addition of Aerobic Exercise

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age30-55
SponsorCairo University

About this trial

Familial Mediterranean fever (FMF) affect liver and causes some dysfunctions including non-alcoholic fatty liver.. still exercise and diet limitation is the treatment for this case

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

familial Mediterrean fever women

obese women

women who have fatty live (non alcoholic type)

Disqualifiers

cardiac patients

respiratory disease

renal disease

cancer

Trial design

Design model

Parallel

Treatments tested in this trial

  • exercise plus diet restriction

    Behavioral

    Familial Mediterranean fever (FMF women ) will be collected in this group. the group OF FMF will contain 20 FMF women. the group will follow their colchicine (traditional daily drug therapy for FMF) in addition to Mediterranean diet for six months. also, this group, Group I, will also perform elliptical aerobic exercise (this exercise will be applied for 40 minutes three times weekly and this exercise will be maintained for 6 months)

  • diet restriction

    Behavioral

    Familial Mediterranean fever (FMF women ) will be collected in this group. the group OF FMF will contain 20 FMF women. the group will follow their colchicine (traditional daily drug therapy for FMF) in addition to Mediterranean diet for six months.

Treatment groups

40 Participants
are divided into 2 treatment groups
Group A: group number 1Experimental treatment 1 intervention
Group B: group number 2Active comparator 1 intervention

Trial outcomes

Primary outcomes

1

aspartate transaminase

it is a hepatic enzyme

Time frame
it will be measured after 6 months

Secondary outcomes

1

alanine transaminase

it is a hepatic enzyme

Time frame
it will be measured after 6 months
2

body mass index

it will be measured after patient emptying his bowel and bladder

Time frame
it will be measured after 6 months
3

waist circumference

it will be measured at umbilical level

Time frame
it will be measured after 6 months
4

high density lipoprotein

it will be measured in plasma

Time frame
it will be measured after 6 months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.